| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.00045 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.00038 | 1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.003 | 1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.00033 | 1 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.00015 | 1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 2.4e-05 | 1 |